跳至主要内容
临床试验/ACTRN12614000071628
ACTRN12614000071628终止未知

A randomized controlled trial in ischemic stroke patients with successful endovascular recanalization of therapeutic hypothermia versus standard care using radiological stroke growth as primary outcome and secondary clinical outcomes

Royal Melbourne Hospital0 个研究点目标入组 32 人开始时间: 2014年1月21日最近更新:
适应症

试验速览

阶段
未知
状态
终止
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients with ischaemic stroke who have undergone successful (TICI 2b/3) endovascular recanalization and are being cared for in intensive care
  • Informed consent from patient, person responsible or procedural authorization as approved by HREC
  • Possibility to start hypothermia within 6 hours of stroke onset

排除标准

  • Metallic foreign bodies or severe claustrophobia precluding MRI
  • Severe co-morbidity or dementia (pre-stroke modified Rankin Scale 4-5)
  • Clinical diagnosis of pneumonia or other sepsis at baseline
  • Bradycardia <40bpm at baseline
  • Skin damage (e.g., inflammation, burns, injuries, ulcerations, hives, rash) at the sites intended to be used for cooling
  • Contraindication to sedation and intubation
  • Current participation in another interventional clinical trial

研究者

相似试验